Search - tctmd.com

Displaying 681 - 684 of 684

Sort: Relevancy | Date

Composite Endpoints in Clinical Trials: Why Do We Need Them and How Do You Interpret Them?

Presentation TCT 2012

Composite Endpoints in Clinical Trials: Why Do We Need Them and How Do You Interpret Them?

Presenter: Giuseppe Biondi Zoccai

October 22, 2012

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Presentation

Longitudinal stent deformation: Quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomized controlled clinical trials

Presenter: 53202|Dean Kereiakes

March 28, 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presentation ISET 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presenter: Ramon Quesada

January 16, 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presentation TCT 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presenter: Klaus Bonaventura, Steffen Sonntag, Franz Xaver Kleber

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.